140
Participants
Start Date
February 21, 2017
Primary Completion Date
January 1, 2022
Study Completion Date
August 19, 2022
Cabazitaxel
25mg/m2 q3w
Antihistamine
As intravenous premedication (dexchlorpheniramine 5 mg, diphenhydramine 25 mg, or equivalent)
Corticosteroid
As intravenous premedication (dexamethasone 8 mg or equivalent)
H2 antagonist
As intravenous premedication (ranitidine or equivalent)
Antiemetic
Antiemetic prophylaxis is recommended and can be given orally or intravenously if necessary
Reinier de Graaf Groep, Delft
Admiraal de Ruyter Ziekenhuis, Flushing
Groene Hart Ziekenhuis, Gouda
Canisius Wilhelmina Ziekenhuis, Nijmegen
Erasmus MC, Rotterdam
Franciscus Gasthuis en Vlietland, Rotterdam
Maasstad Ziekenhuis, Rotterdam
Medisch Centrum Haaglanden, The Hague
Tweesteden Ziekenhuid, Tilburg
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Erasmus Medical Center
OTHER